Balyasny Asset Management
VERA icon

Balyasny Asset Management’s Vera Therapeutics VERA Stock Holding History

Balyasny Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.9M Buy
419,570
+365,243
+672% +$15.7M 0.03% 759
2025
Q4 		$2.75M Buy
+54,327
New +$1.93M 0.01% 1715
2025
Q1 		– Sell
-385,425
Closed -$16.3M – 3373
2024
Q4 		$16.3M Buy
385,425
+209,834
+120% +$9.29M 0.04% 756
2024
Q3 		$7.76M Buy
175,591
+169,544
+2,804% +$6.43M 0.02% 1066
2024
Q2 		$219K Buy
+6,047
New +$240K ﹤0.01% 2314
2024
Q1 		– Sell
-10,430
Closed -$160K – 3188
2023
Q4 		$160K Buy
+10,430
New +$132K ﹤0.01% 2343

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return